Header Logo

Jay Steingrub

Concepts (446)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Influenza Vaccines
11
2025
90
2.110
Why?
Influenza, Human
12
2025
191
2.100
Why?
Sepsis
19
2024
272
2.060
Why?
Intensive Care Units
24
2024
423
1.920
Why?
Respiration, Artificial
20
2023
292
1.830
Why?
Hospitalization
31
2025
1290
1.780
Why?
Protein C
10
2012
29
1.280
Why?
Noninvasive Ventilation
7
2021
70
1.280
Why?
Respiratory Insufficiency
7
2021
148
1.040
Why?
Critical Care
12
2024
397
1.020
Why?
Hospital Mortality
17
2024
841
1.000
Why?
Coronavirus Infections
7
2020
192
0.990
Why?
Pneumonia, Viral
7
2020
205
0.980
Why?
Adult
74
2025
15669
0.980
Why?
Middle Aged
76
2025
16317
0.970
Why?
United States
53
2025
7390
0.930
Why?
Vaccination
15
2025
334
0.920
Why?
Humans
129
2025
59360
0.840
Why?
Aged
59
2025
13416
0.820
Why?
Decision Making
8
2024
395
0.770
Why?
Male
74
2025
27739
0.720
Why?
Female
77
2025
30705
0.710
Why?
Acute Lung Injury
8
2019
43
0.690
Why?
Respiratory Syncytial Virus Infections
3
2025
34
0.660
Why?
Professional-Family Relations
7
2024
89
0.660
Why?
Shock, Septic
4
2018
86
0.590
Why?
Critical Illness
11
2023
325
0.580
Why?
Oxygen Inhalation Therapy
1
2018
57
0.570
Why?
Extracorporeal Membrane Oxygenation
1
2018
52
0.550
Why?
Pulmonary Embolism
1
2018
170
0.500
Why?
Recombinant Proteins
7
2012
689
0.460
Why?
Betacoronavirus
3
2020
166
0.460
Why?
Liver Diseases
3
2008
138
0.450
Why?
Neuromuscular Blocking Agents
1
2014
12
0.440
Why?
Fluid Therapy
5
2023
47
0.440
Why?
Communication
5
2019
545
0.440
Why?
Practice Patterns, Physicians'
4
2017
687
0.430
Why?
Treatment Outcome
24
2023
5284
0.420
Why?
Pandemics
10
2023
615
0.410
Why?
Young Adult
15
2025
4267
0.410
Why?
Adolescent
20
2025
5824
0.400
Why?
Blood Group Incompatibility
1
2012
10
0.390
Why?
Vital Signs
1
2012
11
0.390
Why?
Influenza A Virus, H1N1 Subtype
2
2024
86
0.390
Why?
Blood Volume
1
2012
42
0.380
Why?
Transfusion Reaction
1
2012
44
0.380
Why?
Anti-Infective Agents
2
2010
143
0.370
Why?
Length of Stay
8
2021
775
0.360
Why?
Proxy
3
2019
13
0.360
Why?
Case-Control Studies
9
2024
1051
0.350
Why?
Hydroxychloroquine
2
2020
19
0.350
Why?
Antibodies, Viral
3
2022
292
0.350
Why?
Personnel, Hospital
2
2020
41
0.350
Why?
Pregnancy Complications
2
2005
364
0.350
Why?
Retrospective Studies
16
2021
6071
0.340
Why?
Patient Preference
3
2024
78
0.340
Why?
Prospective Studies
14
2024
3067
0.320
Why?
Multiple Organ Failure
5
2018
43
0.310
Why?
Influenza A Virus, H3N2 Subtype
3
2024
26
0.310
Why?
Bias
3
2024
108
0.310
Why?
Hemodynamics
4
2008
230
0.310
Why?
Lung
3
2018
919
0.310
Why?
Severity of Illness Index
10
2022
1479
0.300
Why?
HELLP Syndrome
2
2005
3
0.300
Why?
Pneumonia
5
2021
281
0.290
Why?
Anti-Inflammatory Agents, Non-Steroidal
3
2005
202
0.290
Why?
Logistic Models
9
2021
1232
0.280
Why?
Vasoconstrictor Agents
3
2023
64
0.280
Why?
Fatty Liver
2
2005
98
0.270
Why?
Pre-Eclampsia
2
2005
69
0.270
Why?
Physicians
3
2022
435
0.270
Why?
Cohort Studies
11
2024
2374
0.270
Why?
Hospitals, Teaching
2
2018
101
0.260
Why?
Aged, 80 and over
17
2025
5128
0.260
Why?
Pulmonary Disease, Chronic Obstructive
4
2021
657
0.250
Why?
Shock
2
2008
31
0.240
Why?
RNA, Messenger
7
2023
1465
0.240
Why?
Vaccines, Synthetic
5
2022
68
0.240
Why?
Respiratory Syncytial Virus Vaccines
1
2025
21
0.230
Why?
Immunocompromised Host
2
2022
100
0.220
Why?
Glucocorticoids
2
2015
179
0.220
Why?
Asthma
3
2021
453
0.220
Why?
Respiratory Syncytial Virus, Human
1
2023
22
0.210
Why?
Prognosis
9
2023
1600
0.210
Why?
Venous Thromboembolism
1
2025
141
0.210
Why?
Hypotension
2
2023
48
0.210
Why?
Tidal Volume
2
2019
37
0.210
Why?
Pulmonary Circulation
1
2003
27
0.210
Why?
Neurologic Examination
1
2003
52
0.210
Why?
Goals
1
2023
88
0.210
Why?
Influenza A virus
1
2024
116
0.200
Why?
Bacterial Infections
1
2024
140
0.200
Why?
Outpatients
2
2021
136
0.200
Why?
Comorbidity
7
2017
1078
0.200
Why?
Treatment Failure
6
2021
185
0.200
Why?
Family
3
2024
229
0.200
Why?
Decision Support Systems, Clinical
1
2022
64
0.200
Why?
Emergency Service, Hospital
3
2025
1021
0.200
Why?
Trust
1
2022
67
0.190
Why?
Clinical Trials as Topic
3
2019
441
0.190
Why?
Organ Transplantation
1
2022
53
0.190
Why?
Immunization, Secondary
1
2022
40
0.190
Why?
Propensity Score
2
2014
144
0.190
Why?
Age Factors
5
2012
1504
0.180
Why?
Antibodies, Neutralizing
1
2022
178
0.180
Why?
Attitude of Health Personnel
2
2016
550
0.180
Why?
Brain Injuries
1
2003
135
0.180
Why?
Work
1
2020
15
0.180
Why?
Telecommunications
1
2020
9
0.180
Why?
Heart
1
2003
274
0.180
Why?
Contact Tracing
1
2020
14
0.180
Why?
Interleukin-6
4
2017
310
0.180
Why?
Symptom Assessment
1
2020
44
0.180
Why?
Risk Factors
7
2020
4984
0.170
Why?
Drug Therapy, Computer-Assisted
2
2012
10
0.170
Why?
Blood Glucose
2
2008
461
0.170
Why?
Body Water
1
2000
16
0.170
Why?
Delivery of Health Care
2
2022
408
0.170
Why?
Health Knowledge, Attitudes, Practice
1
2025
724
0.170
Why?
Databases, Factual
5
2016
813
0.170
Why?
Electric Impedance
1
2000
35
0.170
Why?
Electronic Health Records
5
2023
342
0.170
Why?
Optimism
1
2019
5
0.160
Why?
Community-Acquired Infections
1
2020
92
0.160
Why?
Systemic Inflammatory Response Syndrome
3
2005
41
0.160
Why?
Pulmonary Alveoli
1
2019
44
0.160
Why?
Survival Analysis
8
2019
555
0.160
Why?
Catheterization, Swan-Ganz
3
2012
12
0.160
Why?
Body Composition
1
2000
146
0.160
Why?
Interleukin-18
1
2019
71
0.160
Why?
Enteral Nutrition
3
2012
54
0.160
Why?
Double-Blind Method
9
2017
715
0.160
Why?
Intubation, Intratracheal
1
2021
194
0.160
Why?
Patient Care Planning
1
2019
84
0.150
Why?
Recovery of Function
1
2020
270
0.150
Why?
APACHE
7
2019
46
0.150
Why?
Environmental Exposure
1
2020
208
0.150
Why?
Triage
2
2018
109
0.150
Why?
Seasons
3
2024
123
0.150
Why?
Ambulatory Care
1
2020
300
0.150
Why?
Ganciclovir
1
2017
18
0.140
Why?
Hospitals, Community
1
2018
70
0.140
Why?
Inpatients
1
2020
291
0.140
Why?
Cross Infection
2
2020
149
0.140
Why?
Quality of Life
2
2022
1137
0.140
Why?
Advance Directives
1
2017
45
0.140
Why?
Time Factors
7
2023
3617
0.140
Why?
Cytomegalovirus Infections
1
2017
66
0.140
Why?
Cytomegalovirus
1
2017
90
0.130
Why?
Insulin
2
2012
674
0.130
Why?
Glasgow Coma Scale
1
1996
43
0.130
Why?
Acute Disease
4
2019
660
0.130
Why?
Sex Factors
4
2012
935
0.130
Why?
Health Facility Size
1
2015
16
0.130
Why?
Hospitals, Rural
1
2015
19
0.130
Why?
Hospitals, Urban
1
2015
43
0.130
Why?
Stomach Ulcer
1
1995
6
0.120
Why?
Pulmonary Wedge Pressure
3
2011
26
0.120
Why?
Cross-Sectional Studies
5
2025
2373
0.120
Why?
Cardiopulmonary Resuscitation
1
1996
85
0.120
Why?
Wounds and Injuries
1
2017
229
0.120
Why?
Central Venous Pressure
2
2012
12
0.120
Why?
Water-Electrolyte Balance
2
2011
17
0.120
Why?
Truth Disclosure
1
2015
56
0.120
Why?
Antiviral Agents
1
2017
313
0.110
Why?
Fluorobenzenes
1
2014
5
0.110
Why?
Surveys and Questionnaires
2
2018
2513
0.110
Why?
Clinical Trials, Phase III as Topic
2
2010
40
0.110
Why?
Pyrimidines
1
2014
131
0.110
Why?
Clostridium Infections
1
2014
45
0.110
Why?
Stress, Physiological
1
1995
185
0.110
Why?
Sulfonamides
1
2014
121
0.110
Why?
Influenza B virus
2
2024
7
0.100
Why?
Ventilator Weaning
2
2011
19
0.100
Why?
Vaccines, Combined
2
2022
7
0.100
Why?
Disease Progression
4
2021
1122
0.100
Why?
Attitude to Health
1
2015
279
0.100
Why?
Decision Support Systems, Management
1
2012
2
0.100
Why?
Thromboplastin
1
2012
6
0.100
Why?
Programming Languages
1
2012
14
0.100
Why?
Respiratory Rate
1
2012
14
0.100
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2014
206
0.100
Why?
Brain Ischemia
1
1996
399
0.100
Why?
Computers
2
2022
49
0.100
Why?
Fever
1
2012
63
0.100
Why?
Confidence Intervals
2
2010
241
0.100
Why?
gamma-Linolenic Acid
1
2011
16
0.100
Why?
Academic Medical Centers
3
2020
306
0.100
Why?
Eicosapentaenoic Acid
1
2011
14
0.100
Why?
Hospital Administration
1
2012
41
0.090
Why?
Docosahexaenoic Acids
1
2011
30
0.090
Why?
Oxygen
2
2023
313
0.090
Why?
Albuterol
1
2011
24
0.090
Why?
Patient Acceptance of Health Care
1
2016
450
0.090
Why?
Therapeutics
1
1991
6
0.090
Why?
Health Surveys
1
2013
298
0.090
Why?
International Classification of Diseases
1
2012
132
0.090
Why?
Hyperglycemia
1
2012
98
0.090
Why?
Socioeconomic Factors
4
2020
741
0.090
Why?
Antibodies
1
2012
179
0.090
Why?
Adrenergic beta-2 Receptor Agonists
1
2011
34
0.090
Why?
Energy Intake
1
2012
167
0.090
Why?
Health Status
2
2022
424
0.090
Why?
Cost of Illness
1
2012
156
0.090
Why?
Blood Transfusion
1
2012
150
0.090
Why?
Documentation
2
2022
127
0.090
Why?
Biological Products
1
2012
90
0.090
Why?
Heart Rate
1
2012
307
0.090
Why?
Self Report
2
2023
359
0.090
Why?
Recombinant Fusion Proteins
1
2012
490
0.090
Why?
Pregnancy
3
2005
2202
0.080
Why?
Ambulatory Care Facilities
2
2020
102
0.080
Why?
Acute Kidney Injury
1
2011
132
0.080
Why?
Rhabdomyolysis
1
1989
21
0.080
Why?
Antioxidants
1
2011
241
0.080
Why?
Blood Pressure
1
2012
495
0.080
Why?
Multivariate Analysis
2
2010
902
0.080
Why?
Rupture, Spontaneous
2
2005
22
0.080
Why?
Vascular Resistance
3
2003
48
0.080
Why?
RNA
2
2023
401
0.080
Why?
Pulmonary Artery
2
1987
90
0.080
Why?
Chi-Square Distribution
1
2010
409
0.080
Why?
Infusions, Intravenous
4
2018
164
0.080
Why?
Cocaine
1
1989
96
0.080
Why?
Substance-Related Disorders
2
2021
682
0.080
Why?
Ethics
1
1988
1
0.080
Why?
Ethical Review
1
1988
3
0.080
Why?
Ethics Committees, Clinical
1
1988
5
0.080
Why?
Ethics Committees
1
1988
9
0.080
Why?
Embolism, Amniotic Fluid
1
1988
1
0.080
Why?
Castor Oil
1
1988
2
0.080
Why?
Follow-Up Studies
4
2019
2337
0.080
Why?
Risk Assessment
4
2021
1921
0.080
Why?
Internet
1
2012
448
0.080
Why?
Human Experimentation
1
1988
32
0.070
Why?
Drug Administration Schedule
4
2018
283
0.070
Why?
Reproducibility of Results
4
2018
1561
0.070
Why?
Ethics Committees, Research
1
1988
32
0.070
Why?
Odds Ratio
1
2010
745
0.070
Why?
Professional Practice
1
2008
22
0.070
Why?
Biomedical Research
2
2012
256
0.070
Why?
Qualitative Research
3
2017
618
0.070
Why?
Alcohol Withdrawal Delirium
1
1987
4
0.070
Why?
Meningism
1
1987
2
0.070
Why?
Psychoses, Alcoholic
1
1987
2
0.070
Why?
Dose-Response Relationship, Drug
3
2020
806
0.070
Why?
Hydrocortisone
2
2012
187
0.070
Why?
Hemoglobins
1
2008
133
0.070
Why?
Polyethylene Glycols
1
2008
165
0.070
Why?
Randomized Controlled Trials as Topic
2
2021
677
0.070
Why?
Budd-Chiari Syndrome
1
2005
5
0.060
Why?
Hepatolenticular Degeneration
1
2005
6
0.060
Why?
Guideline Adherence
1
2008
290
0.060
Why?
Phospholipases A
1
2005
11
0.060
Why?
Hepatitis B
1
2005
28
0.060
Why?
Acetates
1
2005
33
0.060
Why?
Health
1
1985
31
0.060
Why?
Cholestasis
1
2005
53
0.060
Why?
Hematoma
1
2005
68
0.060
Why?
Indoles
1
2005
107
0.060
Why?
Sentinel Surveillance
1
2024
16
0.060
Why?
Mortality
1
1985
155
0.060
Why?
Respiratory Syncytial Viruses
1
2024
17
0.060
Why?
Anti-Bacterial Agents
1
2010
735
0.060
Why?
omega-N-Methylarginine
1
2004
8
0.060
Why?
Anticoagulants
1
2008
477
0.060
Why?
Nitric Oxide Synthase
1
2004
45
0.060
Why?
Patient Acuity
1
2023
19
0.050
Why?
Hepatitis C
1
2005
143
0.050
Why?
Choice Behavior
1
2024
78
0.050
Why?
Cardiac Catheterization
1
1985
252
0.050
Why?
Survival Rate
2
2019
802
0.050
Why?
Vascular Capacitance
1
2003
2
0.050
Why?
Cardiac Volume
1
2003
7
0.050
Why?
Virus Diseases
1
2024
114
0.050
Why?
Programming, Linear
1
2003
1
0.050
Why?
Ventricular Function
1
2003
22
0.050
Why?
Advisory Committees
1
2024
108
0.050
Why?
Ventricular Pressure
1
2003
30
0.050
Why?
Trauma Severity Indices
1
2003
35
0.050
Why?
Cause of Death
1
2004
210
0.050
Why?
Diastole
1
2003
89
0.050
Why?
Immunization
1
2023
128
0.050
Why?
Viral Load
1
2023
220
0.050
Why?
Transplant Recipients
1
2022
31
0.050
Why?
Antibody Formation
1
2022
108
0.050
Why?
Syndrome
1
2022
170
0.050
Why?
Immunization Schedule
1
2022
17
0.050
Why?
Immunocompetence
1
2022
20
0.050
Why?
RNA, Viral
1
2023
259
0.050
Why?
Language
1
2023
133
0.050
Why?
Insurance Claim Review
2
2012
72
0.050
Why?
Health Services Research
1
2003
265
0.050
Why?
Heart Failure
2
2021
853
0.050
Why?
Vaccination Coverage
1
2021
7
0.050
Why?
Models, Statistical
1
2003
298
0.050
Why?
Health Facilities
1
2021
41
0.040
Why?
Plasminogen Activator Inhibitor 1
2
2012
15
0.040
Why?
Infectious Disease Transmission, Professional-to-Patient
1
2020
5
0.040
Why?
Research Design
2
2018
555
0.040
Why?
Jejunostomy
1
2000
7
0.040
Why?
Jejunum
1
2000
14
0.040
Why?
Seroepidemiologic Studies
1
2020
48
0.040
Why?
Jejunal Diseases
1
2000
7
0.040
Why?
Asymptomatic Diseases
1
2020
46
0.040
Why?
Personal Protective Equipment
1
2020
29
0.040
Why?
Single-Blind Method
1
2020
136
0.040
Why?
Risk
3
2005
364
0.040
Why?
Medical Records Systems, Computerized
2
2012
60
0.040
Why?
Clinical Decision-Making
1
2021
146
0.040
Why?
Antimalarials
1
2020
67
0.040
Why?
Fibrinolytic Agents
1
2001
163
0.040
Why?
Alprostadil
1
1999
6
0.040
Why?
Prevalence
1
2023
1252
0.040
Why?
Hospitals
1
2022
375
0.040
Why?
Withholding Treatment
1
2019
40
0.040
Why?
Nervous System Diseases
1
2021
104
0.040
Why?
Psychotic Disorders
1
2021
149
0.040
Why?
Vasodilator Agents
1
1999
63
0.040
Why?
Liposomes
1
1999
100
0.040
Why?
Accidents, Traffic
1
2000
148
0.040
Why?
Chronic Disease
1
2022
716
0.040
Why?
Predictive Value of Tests
2
2012
1025
0.040
Why?
Mental Competency
1
2019
55
0.040
Why?
Factor Analysis, Statistical
1
2018
98
0.040
Why?
Intention to Treat Analysis
1
2017
18
0.040
Why?
Virus Activation
1
2017
23
0.040
Why?
Data Collection
2
2012
371
0.040
Why?
Drug Carriers
1
1999
175
0.030
Why?
Feasibility Studies
1
2019
525
0.030
Why?
Obesity
1
2005
1166
0.030
Why?
Advance Care Planning
1
2017
61
0.030
Why?
Biomarkers
2
2012
1306
0.030
Why?
Psychometrics
1
2018
362
0.030
Why?
Computers, Handheld
1
2016
38
0.030
Why?
Insurance, Health
2
2011
133
0.030
Why?
Narration
1
2016
42
0.030
Why?
Peptic Ulcer Hemorrhage
1
1995
3
0.030
Why?
Incidence
1
2019
1237
0.030
Why?
Perception
1
2016
167
0.030
Why?
Bronchodilator Agents
1
2015
122
0.030
Why?
Social Work
1
2015
24
0.030
Why?
Patient Selection
2
2005
464
0.030
Why?
Rosuvastatin Calcium
1
2014
3
0.030
Why?
Cardiac Output
2
1991
27
0.030
Why?
Creatine Kinase
1
2014
41
0.030
Why?
Liver Failure
1
2014
17
0.030
Why?
Myocardial Infarction
1
2021
862
0.030
Why?
Physician-Patient Relations
1
2017
396
0.030
Why?
Renal Insufficiency
1
2014
65
0.030
Why?
Nurses
1
2015
102
0.030
Why?
Hemorrhage
2
2008
260
0.030
Why?
Thrombomodulin
1
2012
15
0.030
Why?
Bronchoalveolar Lavage Fluid
1
2012
101
0.020
Why?
Pulmonary Edema
1
2012
28
0.020
Why?
Organ Dysfunction Scores
1
2012
19
0.020
Why?
Interleukin-8
1
2012
87
0.020
Why?
Hematuria
1
2012
19
0.020
Why?
Stroke
1
2021
1127
0.020
Why?
Population Surveillance
1
2013
194
0.020
Why?
Costs and Cost Analysis
1
2012
97
0.020
Why?
Creatinine
1
2011
128
0.020
Why?
Risk Adjustment
1
2011
93
0.020
Why?
Economics, Hospital
1
2011
14
0.020
Why?
Administration, Inhalation
1
2011
145
0.020
Why?
Disease-Free Survival
1
2011
228
0.020
Why?
Health Expenditures
1
2012
113
0.020
Why?
Hospital Departments
1
1990
12
0.020
Why?
Anemia
1
2012
119
0.020
Why?
Practice Guidelines as Topic
1
2015
705
0.020
Why?
Surgery Department, Hospital
1
1990
20
0.020
Why?
Enzyme-Linked Immunosorbent Assay
1
2011
446
0.020
Why?
Radiography, Thoracic
1
2011
110
0.020
Why?
Renal Dialysis
1
2011
189
0.020
Why?
Hospital Costs
1
2011
119
0.020
Why?
Drug Therapy, Combination
1
2011
452
0.020
Why?
Gastrointestinal Tract
1
2012
170
0.020
Why?
Immunoglobulin G
1
2012
446
0.020
Why?
Monitoring, Physiologic
1
1990
149
0.020
Why?
Diabetes Mellitus, Type 2
1
1996
635
0.020
Why?
Dietary Supplements
1
2011
223
0.020
Why?
Sensitivity and Specificity
1
2012
1093
0.020
Why?
Therapeutic Human Experimentation
1
1988
5
0.020
Why?
Government
1
1988
8
0.020
Why?
Respiratory Dead Space
1
2008
2
0.020
Why?
Third-Party Consent
1
1988
9
0.020
Why?
Control Groups
1
1988
12
0.020
Why?
Disseminated Intravascular Coagulation
1
1988
5
0.020
Why?
Social Control, Formal
1
1988
19
0.020
Why?
Fees and Charges
1
1988
18
0.020
Why?
Fetal Death
1
1988
12
0.020
Why?
Federal Government
1
1988
19
0.020
Why?
Terminally Ill
1
1988
17
0.020
Why?
Placebos
1
1988
68
0.020
Why?
Government Regulation
1
1988
40
0.020
Why?
Animals
1
2006
19651
0.020
Why?
Research Subjects
1
1988
40
0.020
Why?
Observation
1
2008
29
0.020
Why?
Random Allocation
1
1988
192
0.020
Why?
United States Food and Drug Administration
1
1988
85
0.020
Why?
Patient Care
1
1988
78
0.020
Why?
Vulnerable Populations
1
1988
84
0.020
Why?
Acquired Immunodeficiency Syndrome
1
1988
138
0.020
Why?
Informed Consent
1
1988
138
0.020
Why?
Age Distribution
1
2008
249
0.020
Why?
Anuria
1
1987
1
0.020
Why?
Oliguria
1
1987
1
0.020
Why?
Patients
1
1988
103
0.020
Why?
Pericardial Effusion
1
1987
16
0.020
Why?
Pharmaceutical Preparations
1
1988
117
0.020
Why?
Research
1
1988
188
0.020
Why?
Point-of-Care Systems
1
2008
120
0.020
Why?
Decision Support Techniques
1
2008
179
0.020
Why?
Cardiomyopathies
1
2008
119
0.020
Why?
Heart Arrest
1
1988
161
0.020
Why?
Heart Diseases
1
1988
206
0.020
Why?
Ovarian Neoplasms
1
1987
130
0.020
Why?
Motivation
1
1988
273
0.020
Why?
Group II Phospholipases A2
1
2005
1
0.020
Why?
Keto Acids
1
2005
3
0.020
Why?
Phospholipases A2
1
2005
12
0.020
Why?
Hospital Bed Capacity, 500 and over
1
1985
7
0.020
Why?
Drug Costs
1
2005
54
0.020
Why?
Europe
1
2005
184
0.010
Why?
Phosphates
1
1985
90
0.010
Why?
Probability
1
1985
166
0.010
Why?
Medical Records
1
1985
133
0.010
Why?
Software
1
2008
367
0.010
Why?
Inflammation
1
2011
1099
0.010
Why?
Patient Admission
1
1985
184
0.010
Why?
Analysis of Variance
1
2005
589
0.010
Why?
Reference Values
1
2004
326
0.010
Why?
Medical Staff, Hospital
1
2003
57
0.010
Why?
Forecasting
1
2003
219
0.010
Why?
Fibrin Fibrinogen Degradation Products
1
2001
13
0.010
Why?
Splenectomy
1
2000
41
0.010
Why?
Likelihood Functions
1
2000
68
0.010
Why?
Fatal Outcome
1
2000
116
0.010
Why?
Models, Biological
1
1985
1143
0.010
Why?
Necrosis
1
2000
140
0.010
Why?
Pancreas
1
2000
147
0.010
Why?
Massachusetts
1
1985
2002
0.010
Why?
Hypoxia
1
1999
112
0.010
Why?
Neoplasms
1
2008
1240
0.010
Why?
Pressure
1
1987
76
0.000
Why?
Abdomen
1
1987
91
0.000
Why?
Steingrub's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (446)
Explore
_
Co-Authors (14)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_